ADICON reshapes board as Carlyle Asia executive joins as non-executive director

ADICON Holdings Limited ( (HK:9860) ) has provided an announcement.

ADICON Holdings Limited has announced that non-executive director Feng Janine Junyuan has resigned from the board and its strategy committee, citing changes in work arrangements, with the company stressing there is no disagreement and thanking her for her contributions. The board has appointed Carlyle Asia managing director Li Bo, a veteran executive with extensive marketing and operational experience in healthcare and consumer sectors, as a new non-executive director, signaling continued alignment with its controlling shareholder and potentially strengthening strategic oversight and industry expertise at board level.

The most recent analyst rating on (HK:9860) stock is a Buy with a HK$8.60 price target. To see the full list of analyst forecasts on ADICON Holdings Limited stock, see the HK:9860 Stock Forecast page.

More about ADICON Holdings Limited

ADICON Holdings Limited is a Cayman Islands–incorporated company listed in Hong Kong that operates in the healthcare sector. Its controlling shareholder is The Carlyle Group’s Asia arm, indicating a strategic focus aligned with private equity–backed growth and operational enhancement in healthcare-related services and markets.

Average Trading Volume: 3,802,652

Technical Sentiment Signal: Sell

Current Market Cap: HK$3.7B

For an in-depth examination of 9860 stock, go to TipRanks’ Overview page.